drugset / Trial / NCT05041725
The Impact of Remimazolam for Postoperative Sedation on the Left Ventricular Systolic Performance in Cardiac Surgery
NaSingle-groupOpen-labelTreatment
Summary
This study analyzes the impact of intraoperative Remimazolam infusion for postoperative sedation on the left ventricular global longitude strain (LV-GLS) patients undergoing cardiac surgery
Timeline
- Start
- 2021-11-01
- Primary completion
- 2022-11-30
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Remimazolam | Small molecule | 1 mg/kg | — |
| Subject | Remimazolam | Small molecule | 2 mg/kg | — |